Parkinson's disease (PD) is a progressive neurodegenerative disease mainly affecting the motor system. To date, the treatment for PD remains symptomatic, and the molecular mechanisms underlying its pathophysiology are still unclear. ?-Synuclein is the major component of protein aggregates in Lewy bodies and Lewy neurites of PD. Mutation or increased expression of ?-synuclein likely contributes to the development of PD. Treatment against the ?-synuclein aggregation might be an efficient therapeutic strategy . TAR DNA binding protein-43(TDP-43), mainly responsible for the pathology of amyotrophic lateral sclerosis, is also involved in PD. The synucleinopathy of PD is more serious when ?-synuclein proteinopathy and TDP-43 proteinopathy coexist, but the effects of interaction between ?-synuclein and TDP-43 in PD remain unclear. This study investigates the effect of TDP-43 on ?-synuclein. Our study found that the deletion of the gene
tdp-1, TDP-43 ortholog in Caenorhabditis elegans (C. elegans), caused behavior defects to improve and human ?-synuclein (HASN) total protein and aggregation to decrease in the HASN overexpressing C. elegans PD model. These effects may be related to upgraded expression of genes belonging to the heat shock protein family,
hsp-70,
hsp-16.1,
hsp-16.11,
hsp-16.41,
hsp-16.48,
hsp-16.4,
hsp-16.2, which were identified through both mRNA sequencing and RNA interference. These studies will further our knowledge on the interactions between TDP-43 and ?-synuclein and their roles in PD. The genes from the heat shock protein family might also be considered as promising therapeutic targets for PD and other ?-synuclein related diseases. This research was supported in part by the Research grant of Garry Wong MYRG2017-00123-FHS.